HUNG-YUAN LIWei, Jung-NanJung-NanWeiMAO-SHIN LINSmith, David JDavid JSmithVainio, JaniJaniVainioLin, Cheng-HsinCheng-HsinLinFU-TIEN CHIANGSHYANG-RONG SHIHHuang, Ching-HueiChing-HueiHuangWu, Mei-YuMei-YuWuHsein, Yenh-ChenYenh-ChenHseinLEE-MING CHUANG2023-02-082023-02-082009-06-270009-8981https://scholars.lib.ntu.edu.tw/handle/123456789/627748The relationship between serum vascular adhesion protein-1 (VAP-1) and plasma glucose in normal and drug-naïve type 2 diabetes subjects is unclear. We examined if serum VAP-1 changed acutely to oral glucose loading and analyzed the relationship between serum VAP-1, fasting plasma glucose (FPG), hemoglobin A1c, and type 2 diabetes.enSemicarbazide-sensitive amine oxidase; Vascular adhesion protein-1; Amine oxidase; Copper-containing 3 (AOC3); Diabetes mellitus; Diabetic complications; SENSITIVE AMINE OXIDASE; DEPENDENT DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; GLUCOSE; COMPLICATIONS; ASSOCIATION; MOLECULE-1; RISK[SDGs]SDG3Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemiajournal article10.1016/j.cca.2009.03.041193362322-s2.0-67349219121WOS:000267279100013https://api.elsevier.com/content/abstract/scopus_id/67349219121